Acura Pharmaceuticals Announces First Quarter Ended March 31, 2021 Financial Results
PALATINE, Ill., May 17, 2021 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in…
Pharmaceuticals, Biotechnology and Life Sciences
PALATINE, Ill., May 17, 2021 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in…
REDUCE-IT® patients experienced substantial cardiovascular (CV) risk reduction with icosapent ethyl regardless of the presence or degree of dyslipidemia, as…
– ANX005 Huntington’s Disease Phase 2 trial fully enrolled with data anticipated 2H 2021 – – ANX009 First-in-Human dose-ranging trial…
– Reported 50% response rate in visual sensitivity among patients in highest dose groups in ongoing Phase 1/2 clinical trial…
COPENHAGEN, Denmark, May 17, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative…
SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it is postponing its…
REDWOOD CITY, Calif., May 17, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced that…
Kathleen Lynch has joined as Head of Global Government Affairs and Communications and Michele Farmer has joined as Chief Accounting OfficerMENLO…
BURLINGAME, Calif., May 17, 2021 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company…
– Recent New Drug Application Resubmission for XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) – – Cohort 1 Data in OASIS…